ASSESSMENT OF RENAL FUNCTIONAL RESERVE IN STAGE II-III OF CHRONIC KIDNEY DISEASE ON THE BACKGROUND OF ANTIAGPLATE THERAPY
Keywords:
chronic kidney disease, kidney functional reserve, glomerular filtration rate, antiplatelet agent, alltrombocepin, dipyridamoleAbstract
The article presents the results of a study to assess the comparative efficacy of antiplatelet drugs dipyridamole and alltrombosepin on the functional reserve of the kidneys in 50 patients at an early stage of chronic kidney disease. Studies have shown that long-term use of alltrombosepin improves the functional reserve of the kidneys. Thus, our studies have once again confirmed that a widely used antiplatelet agent made from local raw materials, alltrombosepin is not inferior to dipyridamole, which is used in chronic kidney disease.
Downloads
References
Gozhenko A.I., Gozhenko E.A., Functional renal reserve in physiology and pathology of the kidneys. Bukov. med., vol. 16,3(63): 2015. 18st.
Ivanov D.D., Kuryata A.V., Garmish I.P. (2018) RAAS blockers: CHD and cardiovascular risk. Kidneys. Kidneys, 2: 13–22.
Karimov M.M., Daminov B.T., Kayumov U.K. Chronic disease of the lungs, medical and social problems and factors of risk and development // Vestnik of the Tashkent Medical Academy. - Tashkent, 2015. - No. 2. - S. 8-12.
Karimov M.M. Voprosy progressirovaniya khronicheskikh bolezney chek s pozitsii ne kotorykh znevev pathogenesis // Vestnik Tashkentskoi meditsinskoi akademii. - Tashkent, 2014. - No. 4. - S. 7-19.
Melnik A. A. Pochki, p-ISSN 2307-1257, e-ISSN 2307-1265 No. 3 (17) 2016 g.
Mikhailova I. E. Antithrombotsitarnye preparations and prevention and treatment of coronary atherothrombosis. Obzor literatury //Vestnik SanktPeterburgskogo universiteta. Series 11. Medicine. - 2014.
Popova L.V., Bokarev I.N. Primenenie antiagregantov v klinicheskoy prakteike, Prakticheskaya meditsina, Cardiology, '6 (82) September 2014g, 22.
Rogova I. V., Fomin V. V., Damulin I. V., Shashkova E. V. Osobennosti cognitivnyx narusheniy and bolnyx chronicheskoy boleznyu pochek na dodializnyx stadiyax: nauchnoe izdanie// Terapevticheskiy arxiv. - 2015. - Volume 85 No. 6. - C. 25-30.
Savitska L.M. (2017). Nirki, 6(2): 32–39.
Sharapov O. N., Mirzaeva G. P., Sabirov M. A. Izuchenie hypoazotemicheskoy effektivnosti preparata cinarozid v klinicheskikh usvoliyax: nauchnoe izdanie // Vestnik Tashkentskoy Meditsinskoy Akademii. - Tashkent, 2014. - N1. - C. 54-56. - Bibliogr.: 12 titles.
Matsushita K., Tonelli M., Lloyd A. et al.; Alberta Kidney Disease
Network (2016) Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) Study equation for estimated GFR. Am. J. Kidney Dis., 60(2): 241–249. 12. National Kidney Foundation (2015) GFR Calculator
(https://www.kidney.org/professionals/kdoqi/gfr_calculator).
Vavilova T.P., Geva O.N., Pushkina A.V., Tkachev G.A., Koretskaia N.A.: Diagnostic and prognostic value of antioxidant enzyme assay in erythrocytes of patients with end stage renal disease treated with hemodialysis// Biomed Khim. – 2016. – Mar-Apr. -52(2). –P219-22.
